Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Vero Cell-Derived H5N1 Influenza Vaccine in Healthy Adults
NCT00517517Phase 2Completed
- Sponsor
- Resilience Government Services
- Start
- Jul 2007
- Primary completion
- Sep 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of inactivated Vero cell based whole virus influenza A/H5N1, sponsored by Resilience Government Services. Started Jul 2007; status: completed.
02
Drugs
inactivated Vero cell based whole virus influenza A/H5N1
Beyond the preview
Go deeper on NCT00517517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00517517.